Request Discount

Narcolepsy Treatment Market (Drug Class - Vasopressors, CNS Stimulants, Decongestants, and Serotonin Reuptake Inhibitors; Narcolepsy Type - Narcolepsy Type 1, and Narcolepsy Type 2; End-user - Retail Pharmacies, Drug Stores, and E-commerce): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : May, 2019

  • Rep Id : HC0040

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Narcolepsy Treatment Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Narcolepsy Treatment Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Narcolepsy Treatment Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on narcolepsy treatment market provides in-depth analysis of segments and sub-segments in the global as well as regional narcolepsy treatment market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional narcolepsy treatment market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global narcolepsy treatment market. According to the report, the global narcolepsy treatment market is projected to grow at a CAGR of 7.8% over the forecast period of 2019-2025.


Market Insight

Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, sleep paralysis, disrupted nighttime sleep, hallucinations, and in some cases episodes of cataplexy. Narcolepsy occurs equally in women and men and is assumed to affect roughly 1 in 2,000 people. Generally, narcolepsy begins between the ages of 15 and 25, but it can become actual at any age. Narcolepsy is identified by taking a medical history, physical exam as well as conducting sleep studies. There are three approaches to the treatment of narcolepsy includes modern medications, lifestyle adjustments, and complementary therapy.


The global narcolepsy treatment market has driven by increasing prevalence’s of narcolepsy due to a surge in stress levels and unhealthy lifestyle. As per the narcolepsy network, it is estimated that only 25% of people who have narcolepsy have been diagnosed and are receiving treatment. Furthermore, growing research and development activities to find a cure for narcolepsy is another factor augments the growth of narcolepsy treatment market. Additionally, increasing demand for advanced therapies for sleeping disorder coupled with rising health care expenditure and reimbursement policies is escalating the growth of the narcolepsy treatment market during the forecast period. However, low awareness among patients about narcolepsy treatment in developing countries is likely to hamper the growth of the global narcolepsy treatment market.


Geographically, the global narcolepsy treatment market is bifurcated into North America, Europe, Asia Pacific, and RoW. North America held a maximum share in the global narcolepsy treatment market. This is due to well-developed infrastructures coupled with rising awareness about the narcolepsy treatment. Moreover, Europe is also anticipated to contribute a significant share in this market due to a rise in R&D activities. Furthermore, the Asia Pacific region is projected to witness the fastest growth rate during the forecast period. The factors such as growing focus on healthcare expenditures, occurrences of lifestyle-related diseases increased investment in the pharmaceutical sector coupled with growth in awareness about health.

Global Narcolepsy Treatment Market


Segment Covered

The report on global narcolepsy treatment market covers segments such as drug class, narcolepsy type, and end-user. On the basis of drug class, the sub-markets include vasopressors, CNS stimulants, decongestants, and serotonin reuptake inhibitors. On the basis of narcolepsy type, the sub-markets include narcolepsy type 1, and narcolepsy type 2. On the basis of end-user, the sub-markets include retail pharmacies, drug stores, and e-commerce.


Companies Profiled:

The report provides profiles of the companies in the market such as Ligand Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., Graymark Healthcare Inc., Arena Pharmaceuticals, Inc., Jazz Pharmaceuticals plc, and Other Companies.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of narcolepsy treatment market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount